3. The latest in the U.S.
COVID-19 has killed over 67,000 Americans and infected over 1.1 million others in less than three months since the first known death in the U.S., Johns Hopkins data shows.
President Trump asserted during a Fox News town hall Sunday night that he's "very confident" the U.S. will produce a coronavirus vaccine by the end of the year, a timeline much more optimistic than what most public health officials have predicted.
Pete Gaynor, who runs the Federal Emergency Management Agency, is drafting a document whose title sounds like the stuff of horror movies: "COVID-19 Pandemic Operational Guidance for the 2020 Hurricane Season," Axios' Jonathan Swan reports.
Don't expect fast action on the next coronavirus stimulus package, known on Capitol Hill as "phase 4." Senior sources in the Republican Senate conference say most GOP senators want to wait a bit before passing another big aid bill, Swan writes.
New York Gov. Andrew Cuomo announced Sunday that New York, New Jersey, Massachusetts, Connecticut, Pennsylvania, Rhode Island and Delaware are forming a regional consortium to reduce competition when purchasing personal protective equipment (PPE).
Gilead Sciences CEO Daniel O'Day said on CBS' "Face the Nation" Sunday that the company has donated its entire supply of the antiviral medication remdesivir to the federal government, which will determine which U.S. cities will receive the drug based on "urgent" need.
White House coronavirus coordinator Deborah Birx said on "Fox News Sunday" that from a public health standpoint, it is "devastatingly worrisome" that protesters in Michigan and around the country are gathering in close quarters and not wearing masks while demonstrating against stay-at-home orders.
Medical schools around the country are fast-tracking soon-to-be graduates so they can join the fight against the coronavirus, Axios' Fadel Allassan reports.
12.3% of New York state has tested positive for novel coronavirus antibodies, Gov. Andrew Cuomo said at a briefing on Saturday.